跳至主要内容
临床试验/NCT04357353
NCT04357353终止3 期

The Role of Platelet Rich Plasma for Erectile Dysfunction

University of Nebraska2 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2021年4月1日最近更新:
适应症

试验速览

阶段
3 期
状态
终止
入组人数
13
试验地点
2
主要终点
Erectile Function Change

研究概览

简要总结

Purpose of Study: This randomized controlled trial investigates the role that platelet rich plasma injections into the penis may play to improve erectile function in men with erectile dysfunction.

详细描述

Eligibility: Men with erectile dysfunction. Ages 50-80. International Index of Erectile Function score of mild (17-21/25) or moderate (8-16/25).

Intervention and Evaluation:Men who consent to join the trial will be randomized to receive either a single injection PRP or saline to the penis. All patients will have blood drawn in clinic the day of injection. Those randomized to PRP arm will have their own blood prepared and separated into the PRP. This solution of their own blood will be injected back into the penis.

Follow Up: Men will be evaluated at 1 , 3, and 6 months after the injections and then asked to complete the IIEF by phone or by electronic means

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
50 Years 至 80 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • history of mild to moderate erectile dysfunction measured by IIEF

排除标准

  • history or prostate cancer treatment (prostatectomy, radiation, brachytherapy)

结局指标

主要结局

Erectile Function Change

时间窗: at 1, 3 and 6 months

The rate of change in erectile function measured by IIEF

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

The Role of Platelet Rich Plasma for Erectile... | 临床试验